WE ARE back to square one. Back to the beginning after 18 months of a V wearying, tortuous series of negotiations that carried on while millions of lives hung in the balance—and still do. The waiver of intellectual property (IP) rights on medicines, vaccines and diagnostics to fight the COVID-19 pandemic sought by India and South Africa—and backed by more than 100 countries at the World Trade Organization (WTO)—has not made much headway, a leaked document reveals.
In fact, experts say the so-called compromise merely reiterates existing flexibilities in the WTO rules and, worse, adds new conditions that are onerous in the extreme.
The document, made public by global health campaigners on March 15 this year, is a purported compromise reached by a quad of interested parties to break the impasse at WTO. It comprises the two movers of the October 2020 proposal and the world's two largest trading blocs, the EU and the US. The agreement, brokered by wro chief Ngozi Okonjo-Iweala, has to be formally approved by the four parties to the secret negotiations that have been going on for some weeks now. That is how uncertain the outcome is. Even if the four parties endorse the current draft, it could also be turned down by other members of WTO, which requires consensus on such matters.
While that may be the case, the leaked compromise begs several questions. First and foremost is why India and South Africa are backing a decision that essentially does little to remove the IP barriers that are blocking the increased production of COVID-19 medical tools, from vaccines and therapies to diagnostic kits, and are thus restricting access to these life-saving products.
Bu hikaye Down To Earth dergisinin April 01, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Down To Earth dergisinin April 01, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Trade On Emissions
EU's Carbon Border Adjustment Mechanism, a tariff on imports, is designed to protect European industries in the guise of climate action.
'The project will facilitate physical and cultural decimation of indigenous people'
The Great Nicobar Project has all the hallmarks of a disaster-seismic, ecological, human. Why did it get the go-ahead?
TASTE IT RED
Popularity of Karnataka's red jackfruit shows how biodiversity can be conserved by ensuring that communities benefit from it
MANY MYTHS OF CHIPKO
Misconceptions about the Chipko movement have overshadowed its true objectives.
The politics and economics of mpox
Africa's mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid
Emerging risks
Even as the world gets set to eliminate substances threatening the ozone layer, climate change and space advancement pose new challenges.
JOINING THE CARBON CLUB
India's carbon market will soon be a reality, but will it fulfil its aim of reducing emissions? A report by PARTH KUMAR and MANAS AGRAWAL
Turn a new leaf
Scientists join hands to predict climate future of India's tropical forests
Festering troubles
The Democratic Republic of Congo struggles to contain mpox amid vaccine delays, conflict and fragile healthcare.
India sees unusual monsoon patterns
THE 2024 southwest monsoon has, between June 1 and September 1, led to excess rainfall in western and southern states such as Gujarat, Maharashtra and Tamil Nadu, while others like Nagaland, Manipur and Punjab recorded a deficit.